Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
Open Access
- 16 October 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 32 (9), 881-887
- https://doi.org/10.1038/sj.bmt.1704239
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in childrenBone Marrow Transplantation, 2001
- Unrelated donor bone marrow transplantation for children with acute leukemia.Journal of Clinical Oncology, 1997
- Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remissionBritish Journal of Haematology, 1996
- The Highest Leukaemia-Free Survival After Allogeneic Bone Marrow Transplantation is Seen in Patients with Grade I Acute Graft-Versus-Host DiseaseLeukemia & Lymphoma, 1996
- Unrelated donor marrow transplantation in childrenBlood, 1995
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Severe Combined Immunodeficiency DiseasePublished by American Medical Association (AMA) ,1977